Company Filing History:
Years Active: 2003-2006
Title: Kinneret Savitzky: Innovator in Molecular Biology
Introduction
Kinneret Savitzky is a prominent inventor based in Tel Aviv, Israel. He has made significant contributions to the field of molecular biology, particularly through his innovative patents. With a total of 5 patents, Savitzky's work has advanced our understanding of critical biological processes.
Latest Patents
Among his latest patents, Savitzky has developed novel splice variants of the CD40 receptor. This invention concerns six unique variants resulting from alternative splicing of the CD40 receptor. Additionally, he has created patents related to vascular endothelial growth factor (VEGF), which include novel nucleic acid and amino acid sequences. This invention also encompasses expression vectors and host cells containing these sequences, as well as pharmaceutical compositions and detection methods utilizing them.
Career Highlights
Throughout his career, Kinneret Savitzky has worked with notable companies, including Compugen Ltd. and Compugent Ltd. His expertise in molecular biology has positioned him as a key figure in the development of innovative solutions in the biotechnology sector.
Collaborations
Savitzky has collaborated with talented individuals in his field, including Liat Mintz and Sharon Engel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.
Conclusion
Kinneret Savitzky's contributions to molecular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the scientific community and drive innovation in biotechnology.